News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Kiener Peter A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 03/27/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2023 |
4
| Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $2.66, valued at
$26.6k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.28, valued at
$122.8k
|
|
| 11/17/2021 |
4
| Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Sold 18,815 shares
@ $17.92, valued at
$337.2k
Sold 1,361 shares
@ $18.02, valued at
$24.5k
Exercised 18,815 options to buy
@ $2.86, valued at
$53.8k
Exercised 1,361 options to buy
@ $2.86, valued at
$3.9k
|
|
| 06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/06/2021 |
4
| Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Granted 10,000 options to buy
@ $12.36, valued at
$123.6k
|
|
| 06/25/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2020 |
4
| Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $3.23, valued at
$64.6k
|
|
| 01/06/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/25/2018 |
4
| Kiener Peter A (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $4.46, valued at
$133.8k
|
|
| 09/14/2018 |
3
| Kiener Peter A (Director) has filed a Form 3 on PIERIS PHARMACEUTICALS, INC. |
| 06/14/2018 |
4
| Kiener Peter A (Director) has filed a Form 4 on Cue Biopharma, Inc.|
Txns:
| Exercised 9,600 options to buy
@ $14.24, valued at
$136.7k
|
|
| 02/13/2018 |
4
| Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Disposed/sold 44,856 shares
@ $18, valued at
$807.4k
Disposed/sold 250,000 options to buy
@ $8.33, valued at
$2.1M
Disposed/sold 38,500 options to buy
@ $14.82, valued at
$570.6k
Disposed/sold 87,203 options to buy
@ $13.8, valued at
$1.2M
Disposed/sold 133,000 options to buy
@ $11.85, valued at
$1.6M
|
|
| 02/13/2018 |
3/A
| Kiener Peter A (Director) has filed a Form 3/A on Cue Biopharma, Inc. |
| 01/04/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/02/2018 |
4
| Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Paid exercise price by delivering 27,496 shares
@ $17.98, valued at
$494.4k
|
|
| 12/27/2017 |
3
| Kiener Peter A (Director) has filed a Form 3 on Cue Biopharma, Inc. |
| 12/11/2017 |
4
| Kiener Peter A (Chief Science Officer) has filed a Form 4 on Sucampo Pharmaceuticals, Inc.|
Txns:
| Sold 50,000 shares
@ $16.5, valued at
$825k
Exercised 50,000 options to buy
@ $8.33, valued at
$416.5k
|
|
| 07/07/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/10/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/08/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/06/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 06/16/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|